A majority of shareholders in AmerisourceBergen (ABC), one of the largest pharmaceutical wholesalers, rejected a proposal that would have required the company to report steps taken to manage the financial and reputational risks associated with the opioid crisis.

However, when subtracting shares held by insiders, including the Walgreen pharmacy chain that owns 26 percent of the stock, the proposal resonated widely. Sixty-two percent of independent shareholders voted in favor, according to Investors for Opioid Accountability, a coalition of socially minded institutional investors that submitted the proposal.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • It is extremely unfair to the American public that suffer from pain. I have a lateral hip tear with severe arthritis in my hip also. It is impossible for me to obtain pain relief, due to this crisis. Focus on the heroin getting into the country. Don’t force Americans to suffer who need it. Focus on bogus doctors. Don’t make the American public suffer in pain!!

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy